These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35787987)

  • 21. Short time to positivity of blood culture predicts mortality and septic shock in bacteremic patients: a systematic review and meta-analysis.
    Hsieh YC; Chen HL; Lin SY; Chen TC; Lu PL
    BMC Infect Dis; 2022 Feb; 22(1):142. PubMed ID: 35144551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-to-positivity, type of culture media and oxidase test performed on positive blood culture vials to predict Pseudomonas aeruginosa in patients with Gram-negative bacilli bacteraemia.
    Cobos-Triguero N; Zboromyrska Y; Morata L; Alejo I; De La Calle C; Vergara A; Cardozo C; Arcas MP; Soriano A; Marco F; Mensa J; Almela M; Martínez JA
    Rev Esp Quimioter; 2017 Feb; 30(1):9-13. PubMed ID: 27897434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.
    Peña C; Gómez-Zorrilla S; Suarez C; Dominguez MA; Tubau F; Arch O; Oliver A; Pujol M; Ariza J
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2791-7. PubMed ID: 22552893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia.
    Siméon S; Le Moing V; Tubiana S; Duval X; Fournier D; Lavigne JP; Erpelding ML; Gustave CA; Desage S; Chirouze C; Vandenesch F; Tattevin P;
    Clin Microbiol Infect; 2019 Apr; 25(4):481-488. PubMed ID: 30036664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
    Gudiol C; Albasanz-Puig A; Laporte-Amargós J; Pallarès N; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Paz Morales H; Brunel AS; García E; Isler B; Kern WV; Morales I; Maestro-de la Calle G; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J;
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
    Ng TM; Teng CB; Lye DC; Apisarnthanarak A
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):49-55. PubMed ID: 24334798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic roles of time to positivity of blood culture in children with Streptococcus pneumoniae bacteremia.
    Li Q; Li Y; Yi Q; Suo F; Tang Y; Luo S; Tian X; Zhang G; Chen D; Luo Z
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):457-465. PubMed ID: 30680552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for mortality in pseudomonas aeruginosa bacteremia in children.
    Chen J; Huang H; Liu C; Fu YQ
    Pediatr Neonatol; 2024 Jan; 65(1):31-37. PubMed ID: 37517970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to positivity of Klebsiella pneumoniae in blood culture as prognostic indicator for pediatric bloodstream infections.
    Cheng J; Zhang G; Li Q; Xu H; Yu Q; Yi Q; Luo S; Li Y; Tian X; Chen D; Luo Z
    Eur J Pediatr; 2020 Nov; 179(11):1689-1698. PubMed ID: 32394266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Value of the Time-to-Positivity in Blood Cultures from Septic Shock Patients with Bacteremia Receiving Protocol-Driven Resuscitation Bundle Therapy: A Retrospective Cohort Study.
    Bae HJ; Kim JS; Kim M; Kim YJ; Kim WY
    Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34201159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae.
    Bang JH; Jung Y; Cheon S; Kim CJ; Song KH; Choe PG; Park WB; Kim ES; Park SW; Kim HB; Oh MD; Lee HS; Kim NJ
    BMC Infect Dis; 2013 Jul; 13():332. PubMed ID: 23870005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time to Positivity as a Prognostic Tool in the Performance of Short-Term Subculture for MALDI-TOF MS-Based Identification of Microorganisms from Positive Blood Cultures in Pediatric Patients.
    Fang C; Zhou Z; Li J; Zhou M; Chen X
    Curr Microbiol; 2020 Jun; 77(6):953-958. PubMed ID: 31989212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to positivity of Corynebacterium in blood culture: Characteristics and diagnostic performance.
    Watanabe N; Otsuka Y; Watari T; Hosokawa N; Yamagata K; Fujioka M
    PLoS One; 2022; 17(12):e0278595. PubMed ID: 36512568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is early time to positivity of blood culture associated with clinical prognosis in patients with
    Hou W; Han T; Qu G; Sun Y; Yang D; Lin Y
    Epidemiol Infect; 2023 Feb; 151():e43. PubMed ID: 36805070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.
    Kim YJ; Jun YH; Kim YR; Park KG; Park YJ; Kang JY; Kim SI
    BMC Infect Dis; 2014 Mar; 14():161. PubMed ID: 24655422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia.
    Su TY; Ye JJ; Hsu PC; Wu HF; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2015 Apr; 48(2):175-82. PubMed ID: 24064286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.
    Ma J; Li N; Liu Y; Wang C; Liu X; Chen S; Xie X; Gan S; Wang M; Cao W; Wang F; Liu Y; Wan D; Sun L; Sun H
    Medicine (Baltimore); 2017 May; 96(21):e6959. PubMed ID: 28538389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia.
    Palmer HR; Palavecino EL; Johnson JW; Ohl CA; Williamson JC
    Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):955-9. PubMed ID: 23397233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.